Alexandria Real Estate Equities retools debt with tender offers, $750M 5.25% notes due 2036

Alexandria retools debt structure with tender offers and new long-term notes

Alexandria Real Estate Equities is reworking its capital structure by tendering older long-dated debt and simultaneously pricing a new public note offering to extend maturities and replace short‑term borrowings. The company sets pricing for cash tenders on its 3.000% (2051), 3.550% (2052) and 4.000% (2050) senior notes under an offer dated Jan. 27, 2026, subject to an aggregate maximum tender cap of $952.2 million. Early‑tender terms include a $50 per $1,000 premium for holders who validly tender by the early date, with acceptance and proration determined under the Offer to Purchase.

In a linked transaction, Alexandria prices $750 million of 5.25% senior notes due 2036 at 99.679% of principal, yielding 5.291%, with the issue fully and unconditionally guaranteed by its Alexandria Real Estate Equities, L.P. subsidiary. The company expects the offering to close on or about Feb. 25, 2026, and names a syndicate of major banks as joint book‑running managers. Alexandria states it plans to use net proceeds to repay commercial paper incurred in connection with repurchases or redemptions of certain series of senior unsecured notes, and to fund general corporate purposes pending deployment.

The combined actions signal a strategic push by the life‑science REIT to manage interest costs and liquidity as it restructures its debt profile. By offering a new 2036 maturity while collecting tenders for longer‑dated issues, Alexandria is effectively lengthening portions of its maturity ladder and replacing floating or short‑term commercial paper with fixed‑rate long‑term securities. The company emphasises that the notes offering is not conditioned on any specific tender result and that acceptance of tendered notes is subject to customary terms, proration and priority provisions.

Shareholders Foundation issues litigation notice on LIC assets

Separately, the Shareholders Foundation notifies certain Alexandria investors of a pending lawsuit regarding the company’s Long Island City life‑science portfolio, alleging that the firm overstated leasing spreads, occupancy prospects and the robustness of its development pipeline. The Foundation urges investors who purchased shares before Jan. 27, 2025 and still hold them to preserve trade confirmations and consider counsel; it clarifies it is a monitoring service, not a law firm.

Operational and regulatory next steps

Alexandria files the note offering under an effective Form S‑3 registration and notes customary closing conditions apply; its releases stress the communications are not offers to sell. Acceptance of tendered notes and the ultimate use of proceeds will proceed under the timelines and terms set out in the company’s Offer to Purchase and related prospectus supplements.